You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TS overexpression confirmed by fresh biopsy (RTPCR)

Showing 1 - 25 of 9,868
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Los Angeles, Minneapolis, Toronto (NB1011)

Completed
  • Tumors
  • Los Angeles, California
  • +2 more
May 10, 2022

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Structural Description of Skin Biopsies With Dynamic Full-field

Recruiting
  • Basal Cell Carcinoma
  • Tomography, Optical Coherence
  • Dynamic full-field optical coherence tomography analysis of skin biopsy or resection
  • Chalon sur Saône, Saône-et-Loire, France
    Centre Hospitalier William Morey - Chalon sur Saône
Jan 26, 2023

Nsclc Trial in Lille (procedure, drug, biological)

Terminated
  • Nsclc
  • Clinical exam
  • +5 more
  • Lille, France
  • +1 more
Oct 14, 2021

Pancreatic Cancer, Gastric Cancer Trial in Hangzhou (Biopsy of tumor tissue for organoid culture)

Recruiting
  • Pancreatic Cancer
  • Gastric Cancer
  • Biopsy of tumor tissue for organoid culture
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of med
Apr 22, 2023

Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 11, 2023

Covid-19 Associated Mucormycosis: a Multicenter Study in Iran

Recruiting
  • COVID-19
  • Mucormycosis
    • Isfahan, Iran, Islamic Republic of
      Isfahan University of Medical Sciences
    Oct 26, 2021

    Fertility Attitudes of Adolescents and Young Turner Syndrome and

    Recruiting
    • Fertility Perservation
    • Fertility
      • Bethesda, Maryland
        National Institute of Child Health and Human Development (NICHD)
      Feb 2, 2023

      Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

      Not yet recruiting
      • Nonalcoholic Steatohepatitis (NASH)
      • ASC41 2 mg
      • +2 more
      • (no location specified)
      Jan 30, 2023

      Tumor Rebiopsy in Children and Recurrent or Progressive Solid

      Active, not recruiting
      • Tumor, Solid
      • Re-biopsy
      • Questionnaire
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Oct 10, 2022

      Multiple Sclerosis, Transcranial Direct Current Stimulation Trial in Istanbul (Transcutaneous Spinal Direct Current Stimulation)

      Recruiting
      • Multiple Sclerosis
      • Transcranial Direct Current Stimulation
      • Transcutaneous Spinal Direct Current Stimulation
      • Istanbul, Kadıköy, Turkey
        Cadde Tıp Merkezi
      Oct 31, 2023

      Healthy Male Subjects Trial in Tokyo ([14C] TS-142)

      Completed
      • Healthy Male Subjects
      • [14C] TS-142
      • Tokyo, Japan
        Taisho Pharmaceutical Co., Ltd selected site
      Oct 5, 2022

      Gestational Diabetes in Pregnancy, Type 2 Diabetes Trial in Lexington, Louisville (Fresh Funds for Mom's, Standard Medical care,

      Not yet recruiting
      • Gestational Diabetes Mellitus in Pregnancy
      • Type 2 Diabetes Mellitus
      • Fresh Funds for Mom's
      • +2 more
      • Lexington, Kentucky
      • +1 more
      Jul 28, 2023

      Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)

      Recruiting
      • Biliary Tract Cancer
      • D07001-softgel capsules + Xeloda (or TS-1)
      • mFOLFOX
      • Kaohsiung, Taiwan
      • +4 more
      Dec 22, 2022

      NASH - Nonalcoholic Steatohepatitis Trial in Canada, Puerto Rico, United States (BIO89-100)

      Active, not recruiting
      • NASH - Nonalcoholic Steatohepatitis
      • Birmingham, Alabama
      • +87 more
      Sep 5, 2022

      NASH - Nonalcoholic Steatohepatitis Trial in Korea, Republic of, United States (HM15211, Placebo of HM15211)

      Recruiting
      • NASH - Nonalcoholic Steatohepatitis
      • Madison, Alabama
      • +46 more
      Jul 14, 2022

      Gastric Cancer Trial (Disitamab Vedotin Combined With Sintilimab)

      Not yet recruiting
      • Gastric Cancer
      • Disitamab Vedotin Combined With Sintilimab
      • (no location specified)
      Jan 31, 2023

      Post-Intubation Tracheal Stenosis and Covid-19

      Recruiting
      • Tracheal Stenosis
      • +3 more
      • tracheal stenosis follow-up file
      • Çankaya, Ankara, Turkey
        Ankara City Hospital
      Jan 11, 2023

      Colorectal Cancer Trial in Guangzhou (Confocal laser endomicroscopy)

      Recruiting
      • Colorectal Cancer
      • Confocal laser endomicroscopy
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      May 26, 2023

      Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate

      Not yet recruiting
      • Cancer of Cervix
      • Apoptosis
      • Immunohistochemistry
      • (no location specified)
      Nov 17, 2023

      Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

      Recruiting
      • Endometrial Cancer
      • Uterine Cancer
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center
      Sep 27, 2022

      Diabetes, PreDiabetes, Food Insecurity Trial in Bronx (Fresh Takes!)

      Not yet recruiting
      • Diabetes
      • +2 more
      • Fresh Takes!
      • Bronx, New York
        Montefiore Bronx Health Collective
      Aug 31, 2023

      Metastatic Breast Cancer in Patients Treated With CDK4/6

      Recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +2 more
      • Cytology Specimen Collection Procedure
      • +2 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      May 6, 2022

      Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

      Terminated
      • Hepatocellular Carcinoma
      • Renal Cell Carcinoma
      • APL-501
      • +2 more
      • Albury, New South Wales, Australia
      • +8 more
      May 3, 2022